Erythemato-telangiectatic (E-T) Subtype
Characterized by diffuse erythema and telangiectasias on the cheeks, forehead, dorsal nose, or entire face.
- Patients often complain of intolerance or sensitivity to topical products and cosmetics.
- Though considered the mildest form of rosacea, the E-T subtype is marked by significant impact on quality of life stemming from persistent facial erythema.
- This type is best treated with avoidance of flushing, photoprotection, and electrosurgery or laser therapies to treat the erythema and telangiectasias.
A significant advancement in treatment of rosacea erythema is now commercially available; once-daily application of brimonidine tartrate gel 0.33% (alpha adrenergic receptor agonist) (such as Mirvaso gel) has shown great promise as an effective topical treatment for facial redness in rosacea.